Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Greencashon Oct 29, 2019 11:09am
53 Views
Post# 30281385

Announces Departure of Chief Advocacy Officer, John Fowler

Announces Departure of Chief Advocacy Officer, John Fowler

 

ORIGINAL: Supreme Cannabis Announces Departure of Chief Advocacy Officer, John Fowler

 

2019-10-29 11:00 ET - News Release

 

TORONTOOct. 29, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) announced that, effective today, it has parted ways with its Chief Advocacy Officer, John Fowler.

The Company wishes to thank Mr. Fowler for his years of dedication and strong contribution to Supreme Cannabis and his passion for the cannabis plant. Mr. Fowler was one of the original founders of Supreme Cannabis' flagship brand, 7ACRES, and is a strong believer in the cultivation of high-end cannabis. As a pioneer and passionate advocate for legalization, the Company knows Mr. Fowler will continue to be a strong contributor to our cannabis community.

"We all wish John the best in his next endeavor and thank him for his commitment to the Company for the last four years. John recognized the value of high-quality cannabis at scale and was instrumental in the creation of 7ACRES," said Navdeep Dhaliwal, CEO of Supreme Cannabis. "The Company and its strong management team is excited to continue its path to growth as a leader in differentiated cannabis brands and premium cultivation at scale, while exporting our team's vast knowledge and experience globally."

Supreme Cannabis remains committed to cementing its footprint in the Canadian cannabis industry as the leading producer of high-quality cannabis at scale with world-class facilities. The Company will continue to deliver differentiated brands and experiences that are enjoyed by all cannabis consumers. Amidst all the industry noise, Supreme Cannabis has taken a strategic and disciplined approach to develop a focused core business and is excited to export that knowledge to the international cannabis market. 

About Supreme Cannabis.

The Supreme Cannabis Company, Inc. is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world's fastest-growing, premium plant driven-lifestyle companies by effectively deploying capital, with an emphasis on disciplined growth and high-quality products.

Supreme Cannabis' portfolio includes 7ACRES, its wholly-owned subsidiary and multi-award-winning brand; Blissco, a wellness cannabis brand and a multi-licensed processor and distributor based in British ColumbiaTruverra Inc., a global medicinal cannabis brand and licensed cultivator; Cambium Plant Sciences, a plant genetics and cultivation IP company; Medigrow Lesotho, an cannabis oil producer located in southern AfricaSupreme Heights, an investment platform focused on CBD brands in the UK and Europe and a brand partnership and licensing deal with Khalifa Kush Enterprises Canada.

Supreme trades as FIRE on the Toronto Stock Exchange (TSX: FIRE), SPRWF on the OTC Exchange in the United States (OTCQX: SPRWF) and 53S1 on the Frankfurt Stock Exchange (FRA: 53S1). Follow us on InstagramTwitterFacebook and YouTube

We simply grow better.

Forward-Looking Information.

 


Bullboard Posts